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Abstract 
Among wide variety of plants only few species are able to produce milky fluid called latex. This 
contains a complex mixture of plant proteins like lectins, chitinases, proteinases etc. which exhibit 
a specific biochemical property. Jatropha curcas, a perennial plant widely found in tropical and 
sub tropical region is well known for its great capacity of producing latex. The plant mainly grown 
for biodiesel production has potential medical applications for a variety of human diseases. The 
latex of Jatropha contains alkaloids and lectins like Curcin, a protein which is proposed to exhibit 
antitumor properties. This protein has a sequence similarity with RIP family of proteins which are 
known for their anti cancerous nature. Preliminary studies suggested the use of Curcin as a part of 
antitumor treatment. Changing lifestyle and ageing in the developing world has resulted in rising 
number of individuals suffering from cancer.  In order to assist further development in cancer 
related drug discovery, naturopathy and to widen the scope of research an in-silico study was 
performed in search for potential targets of Curcin which can be exploited to treat cancer. 
Homology modeling was done to predict the structure of Curcin molecule and protein-protein 
docking operation was carried out using EGFR and mTOR as target receptors. Interestingly the 
results went in the favor of Curcin efficiently proving its anti malignant property.  However, the 
predicted model has to go for clinical trials to establish its effectiveness as an inhibitor of tumors 
caused by EGFR over expression.  
Keywords: Jatropha curcas, anti malignant, Curcin, EGFR, in-silico study.  
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Introduction 
Latex is widely distributed in plants and about 12,000–35,000 species have been reported to 
contain it. It is a milky fluid consisting of a liquid serum holding, either in suspension or solution, 
constituting a complex mixture of molecules. A wide range of proteins is found in latex fluids, 
such as carbohydrate-binding proteins (lectins) and N-acetyl-β-d-glucosaminidases which were 
purified from Hevea brasiliensis latex. Chitinases were detected in Carica papaya and Ficus 
microcarpa latexes. Proteolytic enzymes (serine and cysteine types) are more profuse proteinases 
found in latex fluids. Cysteine proteinases have been recently purified to homogeneity from 
distinct latex fluids and papain which is found in the latex of C. papaya, has been constantly 
studied since it was discovered. Evidences have supported the possible involvement of latex 
proteins in the plant defense mechanisms. However, additional information about its occurrence, 
biological activities and structure of latex proteins is still required to confirm this hypothesis. 
Jatropha curcas (Euphorbiaceae) is a small shrub of about 5- 8 m in height. It has a soft bark and 
milky latex. It is a drought resistant, perennial plant that grows even in the marginal and poor soil.  
The Jatropha curcas is found mainly in 
tropical regions and to a lesser extent in sub-
tropical areas. The plant is well-known for its 
great capacity of producing latex which 
exudates from the stem. There is an emergent 
demand in popular medicine for the different 
parts of the plant, including the latex, and as a Figure 1.1: Image of Jatropha curcas plant 
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consequence a vast literature describes it‟s the related potential. However there is inadequate 
information about biochemical properties of the latex of Jatropha curcas.            
The latex is used for treating tumors; ulcers and wound healing in traditional medicine, the leaves 
of the plant are used as a haemostatic and are also drastic purgative. The major constituents of 
latex are lectins and phorbolesters, curcacycline-A, jatrophine and curcin. These constituents 
indicate pharmacological properties like coagulant activity of the latex from Jatropha curcas 
showed that whole latex significantly reduced the clotting time of human blood. Diluted latex, 
though, prolonged the clotting time: at high dilutions, the blood did not clot at all. This shows that 
this latex possesses both procoagulant and anticoagulant activities.  
The motivation factor of this study is the lack of information available about latex proteins from 
Jatropha curcas. Some preliminary experiments which were conducted earlier in our laboratory 
suggested that the latex could be used as a part in antitumor treatment and also treatment of various 
other diseases. In an attempt to investigate this hypothesis, further in-silico characterization of the 
latex protein was performed to obtain new information on the occurrence and its biological 
activity. 
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Plants of pharmacological importance 
Various ethno-pharmacological surveys conducted among herbal practitioners have revealed a 
large number of laticiferous plant species are used as source of herbal therapies. Plant derived 
compounds have played an important role in the development of several anticancer agents. Almost 
all present medicines come from medicinal plants and are obtained from research on medicinal 
plants. Ethno medicines were earlier used by hunters for themselves and their hunting dogs. Plant 
based medicines are used to treat snakebites, scorpion stings, for injuries and to help hunting 
success. With the altering pattern of life style most of the diseases are now becoming common. 
The traditional system of medicine based on ancient knowledge are chiefly concerned with 
building the body strength which can assist in healing the ailments and these systems rely largely 
on the nature cure (Kumar et al., 1995). The Ayurvedic system has described a large number of 
such medicines based on plants or plant product and the determination of their morphological and 
pharmacological or pharmacognostical characters can give a better understanding of their active 
principles and mode of action. Many plants contain proteins that are capable of inactivating 
ribosome and accordingly are called ribosome-inactivating protein (RIP) (Barbieri et al., 1993).  
 
Modern investigations point out that extracts of Aloe vera act on the dead epithelial cells of the 
skin, aiding their removal from the surface and stimulating the growth of new cells. Thus Aloe is a 
great gift of traditional medicine for shielding the smooth skin of human beings especially when 
radiation damage has assumed an alarming situation due to stratospheric ozone depletion. Fresh 
juice of leaves are also used in liver and spleen troubles and also for eye troubles, found helpful in 
X-ray burns, dermatitis, coetaneous and other skin disorders (Choudhary et al., 2001). Calotropis 
procera is one of the important numbers of traditional herbal medicinal plant in every home of 
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India. The leaves of C. procera are warmed and tied around any body part which is in pain. It is 
practically helpful in backache and in joint pains. Leaf latex if applied on fresh cut it stops 
bleeding without delay (Hattori et al., 1993). 
Jatropha curcas: Its juice is a well known purgative and is helpful in whitlow, convulsions, 
syphilis, neuralgia, dropsy, anasarca, pleurisy and pneumonia. Root bark is applied on the outside 
in rheumatism and is used in sores. It is helpful in chronic dysentery, thirst, abdominal complaints, 
biliousness, anemia, fistula, ulcer, and diseases of the heart and skin (Kumar et al., 2000). 
Euphorbia hirta is demulcent, antispasmodic, antiasthmatic pectoral, anthelmintic and local 
parasiticide. Plant is mainly used in the affections of childhood, in worms, bowel complaints and 
cough, in postnatal complaints, failure of lactation, breast pain. Latex is vermifuge and applied in 
diseases of urino-genitory tract and also in application for warts. Euphorbia tirucalli is useful in 
biliousness, leucorrhoea, leprosy, dropsy, whooping asthma, enlargement of spleen, dyspepsia, 
jaundice, colic tumors, and stones in bladder. Milky juice is useful to itch and scorpion bites 
(Sharma et al., 2001). 
 
Of the tested extracts, the methanol extracts of the plants Acacia nilotica (bark), Euphorbia 
granulata (leaves), Maytenus senegalensis (stem-bark) and aqueous extracts of A. nilotica and M. 
senegalensis showed significant inhibitory effects against HIV-1 PR (Hussein et al., 1999). 
Ganoderma lucidum has been described to have triterpenes which have inhibitory effects against 
HIV-1 protease (Min et al., 1998). 
 
Euphorbiaceae is a large family of about 300 genera and 6000 or more species. Most members are 
trees or shrubs and few are herbs. Some genera (e.g. Euphorbia) are xerophytic (Evans et al., 
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2002). The family of Euphorbiaceae contains many members from milkweeds to poinsettias and 
covering ground from the Americas to India. Euphorbiaceae members have been used in treating 
gonorrhea, asthma, spleen enlargement, as well as tumors (Tiwari et al., 2005). By using a small 
amount of the milky latex or parts of the bark and stem, it does produce a medicinal effect but 
should be noted that in highly concentrated doses has adverse effects. The latex of Euphorbia 
tirucalli has also been researched to eliminate the presence of fascioliasis (Tiwari et al., 2004). 
Euphorbia species have been reported to possess antitumor activity and was recommended to be 
used as anticancer remedies; on the other hand some Euphorbia species have been reported as 
carcinogens. Several other species have been reported to exhibit antimicrobial, antimalarial, 
insecticidal, mollusicidal, anti-inflammatory and antipyretic activities (Natarajan et al., 2005). 
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Jatropha curcas (    ,        ) 
Jatropha curcas, a multipurpose, drought resistant, perennial plant belonging to Euphorbiaceae 
family is achieving a lot of importance for the production of biodiesel. It is a tropical plant that can 
be grown in low to high rainfall areas either in the farms as a commercial crop or on the 
boundaries as a hedge to defend fields from grazing animals and to prevent erosion (Kumar et 
al,.2008). 
 
The genus Jatropha belongs to tribe Joannesieae in the Euphorbiaceae family and consists of 
approximately 170 known species. Linnaeus (1753) was the first to name this physic nut Jatropha 
L. in “Species Plantarum” and this is still applicable today. The genus Jatropha contains 
approximately 170 known species (Agaceta et al., 1981). The genus name Jatropha derives from 
the Greek jatros (doctor), trophe (food), which implies its medicinal uses (Felke et al., 1914). The 
lifetime of the Jatropha curcas plant is more than 50 years. The physic nut, by definition, is a small 
tree or large shrub, which can reach a height of three to five meters, but under favourable 
conditions it can attain a height of 8 or 10m. The plant displays articulated growth, with 
amorphological discontinuity at each growth. The branches have latex. Normally, five roots are 
produced from seedlings, one central and four peripheral. A tap root is not generally formed by 
vegetatively propagated plants. Leaves five to seven lobed, hypostomatic and stomata are of 
paracytic (Rubiaceous) kind. 
 
The species, though native to America, is currently almost pantropical and widely planted as a 
medicinal plant which soon tends to establish itself. It is listed as a weed in Brazil, Fiji, Honduras, 
India, Jamaica, Panama, Puerto Rico, and Salvador (Holm et al., 1979).  
~ 8 ~ 
 
A diversity of plants contains endopeptidases in their latex as part of their protein constituents. For 
example, latex from the unripe fruit of the papaya Carica papaya L. consists a mixture of cysteine 
endopeptidases, such as papain (EC 3.4.22.2), chymopapains A and B (3.4.22.6), papaya 
endopeptidase III, papaya endopeptidase IV (1, 2) and a just identified one designated as 
endopeptidase W. Fresh or dried latex obtained from stem or seeds of J.curcas following injury 
contains proteolytic enzymes. The bleeding procedure goes on for a few minutes until a latex clot 
forms on the affected area. This process of defense resembles blood coagulation and clot formation 
during wounding in mammals (Silva et al., 1997). 
3.1 Possible uses of Jatropha curcas plant 
 
Jatropha has become famous mainly for the production of biodiesel; besides this it has several 
medicinal applications too. Most parts of this plant are used for the treatment of various human and 
veterinary ailments (Shukla et al., 1982). The white latex serves as a disinfectant in oral cavity 
infections in children. The latex of Jatropha contains alkaloids including Jatrophine, Jatropham and 
curcain with anti-cancerous properties (Montanaro et al., 1973). It is also used superficially against 
skin diseases, piles and sores among the domestic livestock.  
All parts of Jatropha (seeds, leaves and bark) have been used extensively in traditional medicine 
and for veterinary purposes for a long time. Some compounds (Curcin, Curcacycline A) with 
antitumor activities were reportedly found in this plant (Berg et al., 1995). Substances such as 
phorbol esters, which are poisonous to animals and humans, have been isolated and their 
molluscicidal, insecticidal and fungicidal properties have been confirmed in lab-scale experiments 
and field trials (Nwosu and Okafor, 1995). 
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Table 3.1 : Chemical composition of its various parts of J.curcas 
Various parts Chemical composition References 
 
 
Aerial parts 
 
Organic acids (o and p-coumaric acid, p-OH-
benzoic acid, Protocatechuic acid, Resorsilic 
acid) 
Saponins and Tannins 
 
Hemalatha and 
Radhakrishnaiah (1993) 
 
Stembark β- Amyrin, β- Sitosterol and Taraxerol  
 
Mitra et al. (1970) 
 
 
 
 
Leaves 
Cyclic triterpenes stigmasterol, stigmast-5-en-3β, 
7α -diol, stigmast-5-en-3 β, 7 β -diol, cholest-5-
en-3 β,7α-diol, cholest-5-en-3fl,7 β -diol, 
campesterol, sitosterol, 7-keto- β sitosterol as 
well as the -d-glucoside of sitosterol.  
Flavonoids apigenin, vitexin, isovitexin. 
Leaves also contain the dimer of a triterpene 
alcohol (C63H117O9) and two flavonoidal 
glycosides. 
 
 
Khafagy et al. (1977) 
Mitra et al. (1970), 
Khafagy et al. (1977), 
Hufford and Oguntimein 
(1987) 
 
 
 
Latex 
 
Curcin, 
Curcacycline A, a cyclic octapeptide 
Nath and Dutta (1991) 
Van den Berg et al. 
(1995) 
 
 
Seeds 
 
Curcin, a lectin  
Phorbolesters  
Esterases  
Lipase  
Staubmann et al. (1999) 
Stirpe et al. (1976) 
Adolf et al. (1984), 
Makkar et al. (1997) 
 
Kernel and 
press cake 
Phytates,  
Saponins  
Trypsin inhibitor 
Aregheore et al. (1997), 
Makkar and Becker 
(1997), Wink et al. (1997) 
 
 
Roots  
β Sitosterol and its β -d-glucoside, marmesin, 
propacin, the 
curculathyranes A and B and the curcusones A-D. 
Diterpenoids jatrophol and jatropholone A and B, 
the coumarin tomentin, the coumarino-lignan 
jatrophin as well as taraxerol. 
 
 
Naengchomnong et al. 
(1986, 1994) 
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The leaves have apigenin, vitexin and isovitexin etc. which along with other factors enable them to 
be used against malaria, rheumatic and muscular pains (Duke et al., 1981). Antibiotic activity of 
Jatropha has been observed against organisms including Staphylococcus aureus and Escherichia 
coli (Thomas et al., 2003). There are some chemical compounds counting curcin (an alkaloid) in 
its seeds that make it unsuitable for common human consumption. The roots are well-known to 
contain an antidote against snake venom. The root extract is also used to check bleeding from 
gums. The leaf, fruits, latex and bark contain glycosides, tannins, phytosterols, flavonoids and 
steroidal sapogenins that exhibit broad ranging medicinal properties. The plant products exhibit 
anti-bacterial and anti-fungal activities (Debnath et al., 2008). The latex from Jatropha curcas 
promotes healing of wounds, refractory ulcers, septic gums and in cuts and bruises. The wound 
healing property was observed due to the presence of curcin, the protease isolated from the latex 
from the plant J. curcas. Healing of the wound by the curcin ointments was found to be better than 
nitrofurazone ointment and propamidine isethionate cream in mice (Nath et al., 1992). 
Dried latex and chloroform extract of roots has been reported to consist of anti-inflammatory 
activity (Basu et al., 1994). Aqueous extract of the latex has been found to exhibit analgesic, 
antipyretic and anti-inflammatory activity. A single dose of the aqueous suspension of the dried 
latex was effective to a significant level against the acute inflammatory response (Kumar et al., 
1994). 
 
The latex of Jatropha curcas has also been used for the synthesis of silver nanoparticles. Some of 
the major components in the latex of Jatropha curcas were identified as curcin, curacycline A and 
curacycline B. The silver nanoparticles obtained using this source had two broad distributions- one 
having particles in the range of 20-40 nm and the other having larger and uneven particles. 
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Molecular modeling studies of the peptides in the latex revealed that the silver ions were first 
entrapped in the core structure of the cyclic structure of the protein and were then reduced and 
stabilized in situ by the amide group of the peptide. This resulted in particles with radius similar to 
the peptides. It was also found that the larger particles with uneven shapes were stabilized by the 
enzyme curcain (Bar et al., 2009). 
 
Many of these traditional medicinal properties of Jatropha curcas are required to be investigated 
in depth for the marketable therapeutic products along with the toxicological effects thereof.  
 
3.2 Pharmacological properties of latex 
 
Plant latex is the cytoplasm of extremely specialized cells known as laticifers. Proteins are 
abundantly accumulated in latex and are involved in the defense system. One important 
characteristic of laticifers is that they have various toxic compounds in the latex; for example, the 
neurotransmitter dopamine in the Persian poppy (Papaver bracteatum), narcotic alkaloid morphine 
in the opium poppy (Papaver somniferum), and insecticidal compounds such as the glycosidase 
inhibitors 1,4-dideoxy-1,4-imino-d-arabinitol (d-AB1) and 1-deoxynojirimycin (DNJ) in mulberry 
In addition, cysteine protease in latex of papaya (Carica papaya) and wild fig (Ficus virgatalatex) 
is lethal to caterpillars of herbivorous insects. The latex itself is a secondary metabolite and is 
combination of compounds such as phytosterols, amine oxidases and as well as many others 
(Phelps et al., 2008). The latex itself has been found to be powerful inhibitors to watermelon 
mosaic virus (Tewari and Shukla, 1982). The leaves and latex are used in healing of wounds, 
refractory ulcers, and septic gums and cuts and bruises. A proteolytic enzyme (curcain) has been 
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reported to contain wound healing activity in mice (Nath and Dutta, 1997; Villegas et al., 1997). 
Investigation of the coagulant activity of the latex of Jatropha showed that whole latex notably 
reduced the clotting time of human blood. 
 
Curcin, a protein obtained from seeds and latex of Jatropha curcas is proposed to have antitumor 
properties (Lin Juan et al., 2003). This is one of the major proteins in the Jatropha curcas latex, is 
similar to Ricin & Abrin proteins of Ricinus communis and Abrus precatorius, respectively in 
function like in inhibiting protein synthesis in whole cells and in cell-free systems. (Baloch et al., 
2005) found such properties are contained by the latex that supports this. But the elaborate studies 
regarding the structural and functional properties of curcin and the mechanism of action has not 
been reported. The anticancerous property of curcin on gastric cancer cell line and human 
hepatoma has proved (Juan et al., 2003). 
 
Different effects of curcin on different cells examined were observed, with SGC-7901, Sp2/0 and 
human hepatoma being the most sensitive to curcin, and HeLa cells being the most resistant to 
curcin. The curcin had a powerful inhibitory action upon protein synthesis in reticulocyte lysate 
with an IC50 (95% confidence limits) value of 0.19 (0.12-0.27) nmol/L. The IC50 (95% confidence 
limits) of curcin on SGC-7901, Sp2/0, and human hepatoma was 0.23 (0.16-0.32) mg/L, 0.66 
(0.36-0.97) mg/L, 3.16 (2.75-3.58) mg/L, respectively. Curcin was found to have no toxic to HeLa 
cells and normal cells (MRC). This shows that curcin is suitable for the preparation of 
immunotoxins (L. Williams and D.J. Newman, 2005). 
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The evaluation of anticancer and anti-HIV activities of latex extracts from nine medicinal plants 
collected in Zaire was carried out against the National Cancer Institute (NCI) panel of human 
tumor cell lines provided for the preliminary screening of natural products. The methanol extracts 
from the root bark of Hymenocardia acida, the stem bark of Mangifera indica and the leaves of 
Sida rhombifolia, exhibited cytotoxic activity against the 60 human cell lines was checked. Out of 
these, the methanol extract from M. indica produced a remarkable interesting pattern of differential 
cellular sensitivity against the MDA-MB-231, MDA-MB-435, and MDA-N human breast cancer 
cell lines. In the AIDS-antiviral screen, the methanol extract from Jatropha curcas was found to 
produce a moderate cytoprotective effect against HIV in cultured human lymphoblastoid CEM-SS 
cells (Muanza  et al., 1995). 
 
3.3 Antitumor action mechanism of latex 
 
Curcin a major constituent of J. curcas latex, is frequently classified as a lectin and described as 
being comparable to ricin from castor bean with the implication that it has similar toxicity. But all 
of these are incorrect statements. Both curcin and ricin are ribosome inactivating proteins (RIPs), 
which depurinate rRNA, thus inhibiting protein synthesis (Andrew et al., 2009). Thus curcin is 
classified under the RIP superfamily of proteins.  
 
For a long time the attention in RIP (ribosome-inactivating proteins) has been focused on 
developing antitumor drugs that selectively target to tumor cells. A comparison of the amino acid 
sequences of curcin with other RIP, e.g., ricin A-chain and trichosanthin revealed that there existed 
relatively high resemblance among them. The percentages of identity between curcin and ricin A-
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chain, and between curcin and trichosanthin were found to be 54 % (156/287), 57 % (138/241) 
respectively (Chow et al., 1990). 
 
The RIPs are RNA N-glycosidases (Barbieri et al., 1993) that inactivate ribosomes by site-
specifically cleaving the single N–C glycosidic bond between adenine and ribose at A4324 in the 
28s rRNA. The depurination of the specific adenine prevents the elongation factor (EF-2) from 
binding to the 60S subunit, thus RIPs can inhibit protein synthesis. Interest in RIPs has arisen from 
their potential medical and therapeutic applications because many of these proteins have been 
found to be more toxic to tumor cells than normal cells (Lin et al., 1970). Studies have shown that 
they can be used as toxic components of immunotoxins targeted at tumor cells (Bolognesi et. al., 
2004), abortifacients (Jin et. al., 1985) and antiviral agent (Au et al., 2000; Wang et al., 2002) in 
patients suffering with AIDS.  
 
On the basis of structure of the genes and mature proteins (Van Damme et al., 2001), RIPs are 
classified into three types. Type 1, such as trichosanthin (Pan et al., 1993), bryodin (Stirpe et al., 
1986), a,b-momorcharin (Husain et al., 1994; Yuan et al., 1999) and luffin a, b (Kamenosono et 
al., 1988), consist a single polypeptide chain and have alkaline isoelectric points. They have potent 
capabilities to inhibit protein synthesis in the cell free system, but are relative non-toxic to the 
intact cell. Type 2, such as ricin (Rutenber et al., 1991) and abrin (Tahirov et al., 1995), having 
two chains, chain A and chain B, linked by disulfide bridges. The A chain have the ribosome-
inactivating property; the B chain contains a lectin domain which interacts with the cell surface 
galactosides and facilitates the entry of the A chain into the cytoplasm of the cell. Thus, some, but 
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not all, type 2 RIPs have stronger toxicities than type 1 RIPs because type 1 RIPs can only enter 
into cells with difficulty, even though they are very active towards isolated ribosome.  
 
Type 3 is one kind of jasmonate-induced protein, such as JIP60 (Chaudhry et al., 1994) from 
maize. It consists of an N-terminal domain similar to other type 1 RIPs and dissimilar C-terminal 
domain of unknown function.  
 
 
 
 
 
 
 
 
 
Figure 3.1: Structure of Different Types of RIPs 
 
Curcin, a protein isolated from latex of J.curcas shows sequence similarity in amino acid with 
RIPs (Chow et al., 1990). Significantly, it can inhibit the proliferation of tumor cells, through the 
induction of apoptosis and differentiation (Xie et al., 2006) of cancer cells. In this study, we 
describe the structural and functional analysis of curcin, from the latex of J.curcas. The objective 
would be to find an evidence of anti-malignancy of the latex protein by in-silico approach. 
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Targeted Pathways of Cancer 
The latex protein, Curcin has already been proved to act by inhibiting protein synthesis, the 
characteristic of all RIP family of proteins. Apart from this there are other major pathways which 
contribute to large number of cancerous ailments. The most common being the cancer caused by 
epidermal growth factor receptor over expression. 
The Epidermal Growth Factor Receptor is the cell surface receptor member of EGF family protein 
ligands. It consists of four closely related tyrosine kinase receptors: EGFR (ErbB1), HER2/c-neu 
(ErbB2), HER3 (ErbB3) and HER4 (ErbB4). The receptor is present on the cell surface and is 
activated by specific ligands like 
EGF and TGF-alpha. It functions 
by homo-dimerization of hetero-
dimerization with other family 
member which in turn activates 
its intrinsic intracellular protein-
tyrosine kinase activity.  The 
autophosphorylation of several 
tyrosine residues in EGFR 
activates signaling by several 
downstream proteins in signal 
transduction cascades, like MAPK, AKT and JNK pathways. This leads to DNA synthesis, cell 
migration, adhesion and proliferation. Any mutation that leads EGFR over expression or up 
regulation is associated with a number of cancers, including lung, anal and glioblastoma 
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multiforme. This mutation leads to its constant activation resulting in uncontrolled cell division. 
This phenomenon is thus a target of many anticancer therapeutic approaches like cetuximab, 
erlotinib which are either monoclonal antibody inhibitors or small molecule kinase inhibitor.   
Some naturally occurring inhibitors like Potato Carboxypeptidase Inhibitor (PCI) contains a small 
cysteine module, called a T-knot scaffold, which is also found in some EGF family proteins shows 
antagonistic properties due to the structural similarities. The potato protease inhibitor peptide 
forms complexes with several metallo-carboxypeptidases and inhibits them in a competitive way.  
It consists of 39 amino acids forming a globular core stabilized by three disulphide bridges and a 
C-terminal tail. It inhibits receptor dimerization and receptor trans-autophosphorylation by EGF. 
PCI blocks the formation and activation of ErbB1/HER2 heterodimers which plays a prominent 
role in carcinoma development. It also inhibits Transforming Growth Factor alpha (TGF-a) which 
is up regulated in some human cancers. 
Apart from this other cancer related pathways like that involving Mammalian Target of Rapamycin 
(mTOR) was also taken into consideration in the present study to widen the span of research.  The 
mTOR is a serine/threonine protein kinase that regulates cell growth, survival, proliferation, 
motility, protein synthesis and transcription.  Its inhibition leads to apoptosis or arrest of cells in 
G1 phase of cell cycle. 
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Methodology 
5.1 Tools used to perform in-silico study 
5.1.1 Sequence Alignment Tools  
Sequence alignment is a powerful way to compare novel sequences with previously 
characterized genes. Functional, structural and evolutionary information can be inferred from 
fine designed queries and alignments.  
BLAST 
The NCBI defines Basic Local Alignment Search Tool (BLAST) as a tool that finds regions of 
local similarity between sequences. The program compares nucleotide or protein sequences to 
sequence databases and calculates the statistical significance of matches. As the BLAST 
algorithm detects local as well as global alignments, regions of similarity embedded in 
otherwise unrelated proteins can be detected. Both types of similarity may provide significant 
clues to the function of uncharacterized proteins. BLAST can be used to infer functional and 
evolutionary relationships between sequences as well as help identify members of gene families. 
CLUSTAL X 
Clustal X offers a graphical interface for the Clustal W multiple sequence alignment programs. 
It provides an integrated situation for performing multiple sequence and profile alignments and 
analyzing the results. The output of the sequence alignment is then displayed in a window on the 
screen. Progressive MSA helps to create a guide and to identify the consensus sequence using 
Clustal X. 
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5.1.2 Structure Prediction Tools 
The main objective of structural bioinformatics is the prediction of the 3D structure of a protein 
from its 1D protein sequence. The goal is to determine the shape or fold that a given amino acid 
sequence will adopt. If the two sequences show evolutionary ancestry, they are said to be 
homologous. For such similar sequence pairs we can create a structure of the query protein by 
choosing the structure of the known homologous sequence as a template. This is known as 
comparative modeling. The heart of the procedure is the selection of a suitable structural 
template based on sequence pair similarity. This is further extended by the alignment of query 
sequence to the template structure selected to build the backbone of the query protein. Finally 
the entire structure modeled refinement is done by loop construction and side-chain modeling. 
Focusing in the needs to solve the problem several modeling softwares or programs have been 
developed.  
 
MODELLER 9v4  
It is a program used for homology or comparative modeling of protein three-dimensional 
structures. Built on FORTRAN, it runs on python script file commands and is often used for 
homology or comparative protein structure modeling. MODELLER helps determine the spatial 
restraints from the templates. It generates a number of 3D models of the sequence you submit 
satisfying the template restraints. MODELLER automatically calculates a full-atom model 
protein 3D structure keeping in the constraints of spatial restraints. The restraints can be derived 
from a number of different sources like NMR experiments, cross-linking experiments, 
fluorescence spectroscopy, rules of secondary structure packing (combinatorial modeling), 
image reconstruction in electron microscopy, homologous structures (comparative modeling), 
site-directed mutagenesis, residue-residue and atom-atom potentials of mean force, etc. It is not 
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an automated tool instead is a very precise program. Any error in the format of the sequence 
alignment prevents the MODELLER from performing homology modeling. The program is very 
specific about the extension names of the file formats used for homology modeling. It is a very 
reliable program and it allows the user to specify what he wants in the end result. To choose the 
best possible structure from a collection of models, the program uses a standard DOPE energy 
function. The model with minimum molpdf value is chosen as the best probable structure.  
 
SWISS MODEL 
It is a fully automated protein structure homology modeling server, accessible via the ExPaSy 
web server or from a standalone program DeepView (Swiss Pdb-Viewer). The purpose of this 
server is to make Protein Modeling accessible to all biochemists and molecular biologists 
worldwide. It is developed by the Computational Structural Biology Group at the Swiss Institute 
of Bioinformatics (SIB) and the Biozentrum of the University of Basel. For a given target 
protein, a library of experimental protein structures is searched to identify suitable templates. On 
the basis of a sequence alignment between the target protein and the template structure, a three-
dimensional model for the target protein is generated. Model quality assessment tools are used 
to estimate the reliability of the resulting models. The QMEAN4 score is a composite score 
consisting of a linear combination of 4 statistical potential terms (estimated model reliability 
between 0-1). The pseudo-energies of the contributing are calculated together with their Z-
scores with respect to scores obtained for high-resolution experimental structures of similar size 
solved by X-ray crystallography and can be taken analogous to DOPE score method. 
The present study is based on homology modeling using this web based modeling expert system. 
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5.1.3 Visualization Tools 
 
UCSF Chimera (Chimera) 
Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics (RBVI) 
at the University of California, San Francisco, a program for interactive visualization and 
analysis of molecular structures. It helps us to obtain the structure either directly from the PDB 
site or through many other formats, to localize the ligand that is in the active site and display the 
structure which is protein with the inhibitor. Secondary structure identification can be done, as it 
can show and hide ribbons. The secondary structure can observe motifs of the protein and also 
create a molecular surface around the protein, then color the surface according to different 
properties of the amino acids. Studying the protein-ligand interaction can be done by identifying 
the residues within 5.0A, and then identify the residues involved in the binding and label the 
residue names and types. Chimera shows the hydrogen bonds interaction between proteins and 
ligand. 
 
Energy minimization 
 Before energy calculations can be performed, it is necessary to correct structural 
inconsistencies, add hydrogen, and associate atoms with force field parameters. Clicking 
Minimize dismisses the dialog (unless the option to Keep dialog up after Minimize is checked) 
and may call Dock Prep to perform several tasks to prepare the structure(s). Dock Prep may in 
turn call Add H and Add Charge. Each of the tasks is a checkbox option that can be turned off 
independently if already done or deemed unnecessary. Minimization routines are performed by 
MMTK, which is included with Chimera.  
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PyMOL (Link : www.pymol.org) 
PyMOL is an open-source, user-sponsored, molecular visualization system made by Warren 
Lyford DeLano and commercialized by DeLano Scientific LLC, a private software company 
dedicated to creating useful tools that are universally accessible to scientific and educational 
communities. It is well established for producing high quality 3D images of small molecules and 
biological macromolecules such as proteins. It is one of few open source visualization tools 
available for use in structural biology. The Py portion of the software's name refers to the fact 
that it is extensible by the Python programming language. PyMOL is good for:  
1. Viewing 3D Molecular Structures  
2. Rendering Figures Artistically  
3. Animating Molecules Dynamically  
4. Giving Live 3D Presentations  
5. Sharing Interactive Visualizations  
 
5.1.4 Structure Validation tools 
 
RAMPAGE (Link: http://mordred.bioc.cam.ac.uk/~rapper/rampage.php) 
RAMPAGE is an online tool available for the user free of cost. This software is generally used 
for the secondary structure prediction of the proteins. It is based on Ramachandran Plot 
assessment of a protein model.  
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5.1.5 Docking Tools 
 
HEX 6.3 and HEX_SERVER: Online server (Link: http://www.csd.abdn.ac.uk/hex_server) 
HEX is good & trusted software for docking and free for academic usage. HEX recognizes 
protein and DNA structures in PDB format. It is an interactive protein docking and molecular 
superposition program. The aim of molecular docking is to accomplish an optimized 
conformation for both the protein and ligand and relative orientation between protein and ligand 
such that the free energy of the overall system is minimized. To carry out a docking screen, the 
first prerequisite is a structure of the protein of interest. This protein structure and a database of 
potential ligands provide inputs to a docking program. The accomplishment of a docking 
program depends on two components: the search algorithm and the scoring function. This is a 
free service without login or registration requirement.  
 
 
 
 
 
 
 
 
 
 
 
 
 
~ 24 ~ 
 
5.2 Procedure followed for the in-silico study 
 
 
Amino acid sequence of Curcin was collected from the UniProt Knowledgebase 
and saved in FASTA format
BLAST p was performed for the FASTA sequence of Curcin and sequence 
similarities were studied. Sequences with minimum E value and above 50% 
similarity were collected.
Multiple Sequence Alignment was performed in CLUSTAL X to get the conserved 
sequence of Curcin from the above collected set of related protein sequences.
Homology Modeling was carried out in SWISS-MODEL webserver using the 
conserved sequence and Momorcharin Chain A (another RIP) as template.
Further validation to find the best probable structure was done in RAMPAGE
Structural minimization was done in PyMOL.
Structures of target protiens EGFR, mTOR were collected from PDB database and 
saved in .pdb format. All stuctures were for human proteins.
Protien-Protien docking of the above target protiens with Curcin was performed 
in HEX and interpretation was done on the basis of binding energies of all the 
protiens. PCI was taken as positive control.
The resulting dock model was visualised and analysed in CHIMERA.
Flowchart 5.1: Experimental plan for in-silico studies of Curcin 
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5.2.1 Sequence Alignment  
 
First of all amino acid sequence was searched in NCBI for Curcin and saved in the FASTA format. 
After that using BLAST p in PDB server homologous sequence for Curcin with more than 50% 
sequence similarity were selected and their sequences and PDB structures were saved in FASTA 
format. When performing a BLAST search, a reliable first approach is to identify hits with a 
suitably low E-value, which are considered sufficiently close in evolution to make a reliable 
homology model. 
 
Figure 5.1: Screenshot of BLASTp window of NCBI 
 
Further conserved residues were studied by using CLUSTAL X. The reference sequence input 
being that of Curcin which is compared with a set of sequence data generated from BLASTp 
earlier. The MSA data generated is included in the Appendix. 
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Figure 5.2: Screenshot of CLUSTAL X dialogue box 
5.2.2 Homology Modeling and validation 
 
Homology modeling is based on the logical assumption that two homologous proteins will share 
very similar structures. Because a protein's fold is more evolutionarily conserved than its amino 
acid sequence, a target sequence can be modeled with practical accuracy on a very distantly related 
template, provided that the relationship between target and template can be discerned through 
sequence alignment. Homology modeling is most accurate when the target and template both have 
similar sequences. Comparative ("homology") modeling approximates the 3D structure of a target 
protein for which only the sequence is accessible, provided an empirical 3D "template" structure is 
available with >30% sequence identity. 
All homology models were constructed with the SWISS-MODEL web server. The best model on 
the basis of QMEAN4 score and Z- score was then saved in the PDB format. Further validation of 
the model was done by the RAMPAGE server which uses the PDB format as input. 
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Figure 5.3: Web screen shot of SWISS MODEL server 
 
 
Figure 5.4: RAMPAGE server screenshot 
 
5.2.3 Protein- Protein Docking 
 
The validated model is used to study the receptor-ligand interaction using protein docking in HEX. 
The input for the docking program is given using the „File > Open > Ligand‟ and „File > Open > 
Receptor‟ option in the main window. The Docking and Orientation controls can be found in the 
„Controls‟ option. 
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Figure 5.5: Main program window of Hex 6.3 docking program 
Once both receptor and ligand proteins are given as input, their structures will appear in the 
window. The structures can be toggled to different types of view according to user discretion. The 
docking control is used with following settings: 
 Correlation type : Shape only 
 Post Processing : Energy minimization 
 Solutions: 100 
 Scan step: 1.0 
 Rest default 
Press „Activate‟ to start the docking process. After the process is completed empirical visualization 
is done by adjusting the „Alpha‟, „Beta‟ and „Gamma‟ axis using the Orientation Control. „Shift‟ 
option is used only to avoid any confusion if we are going to generate an overlapped final image. 
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Results and Discussion 
6.1 Sequence Alignment 
The BLASTp of Curcin protein sequence was performed and related sequences based on 50% 
sequence similarity and minimum E-value was collected. Multiple sequence alignment was done 
with the help of CLUSTAL X software using default parameters. CLUSTAL X arranges the 
backbone of the target sequence according to that of the template, using the sequence alignment to 
decide where to position each residue. The conserved sequence was then generated and used for 
modeling. The MSA graph is attached in the Appendix of this thesis report. 
6.2 Homology Modeling 
While modeling the Curcin protein, Momocharin A chain was used as a template. This protein has 
33.47 % sequence identity with Curcin, thus homology modeling was done using this template on 
the SWISS-MODEL web server. Three sets of models were generated by satisfaction of spatial 
restraints. Following were the data obtained after modeling: 
Table 6.1 : SWISS MODEL  QMEAN4 scores 
Curcin Raw scores Z - Score 
Model 1 0.485 - 4.03 
Model 2 0.485 - 4.05 
Model 3 0.485 - 4.06 
Out of these three models, Model 1 was selected for further processes based on lowest Z-score. 
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6.3 Structure Analysis and Verification 
The models obtained after homology modeling were analyzed with RAMPAGE (Ramachandran 
Plot server) for further structure verification. The results obtained are: 
Table 6.2: Analysis of Ramachandran Plot for Secondary Structure Prediction  
 
Model 1: 
 
 
Number of residues in favored region (~98.0% expected): 634 (94.1%) 
Number of residues in allowed region (~2.0% expected): 32 (4.7%) 
Number of residues in outlier region: 8 (1.2%) 
 
Model 2: 
 
 
Number of residues in favored region (~98.0% expected): 635 (94.2%) 
Number of residues in allowed region (~2.0% expected): 30 (4.5%) 
Number of residues in outlier region: 9 (1.3%) 
 
Model 3: 
 
 
Number of residues in favored region (~98.0% expected): 628 (93.2%) 
Number of residues in allowed region (~2.0% expected): 32 (4.7%) 
Number of residues in outlier region: 14 (2.1%) 
 
Model No.1 was selected as the best model as per Ramachandran Plot analysis since it has least 
number of residues in outlier region. 
 
 
 
Fig 6.1 Ramachandran Plot for Curcin 
(Model No. 1) 
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6.4 Structure minimization and visualization using Chimera and PyMol of 
proteins under study 
 
  
            Figure 6.2 (a): Curcin                Figure 6.2 (b): mTOR with Rapamycin 
 
            
Figure 6.2 (c): Potato Carboxypeptidase Inhibitor Figure 6.2 (d): EGFR intracelluar domain 
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6.5 Protein-Protein docking studies 
Docking is a method which predicts the preferred orientation of one molecule to a second when 
bound to each other to form a stable complex.  
Interaction of Curcin with mTOR 
After docking operation of ligand „Curcin‟ with „mTOR‟ receptor it is observed that the curcin 
binds preferentially to the opposite side of Rapamycin binding region which is responsible for 
inhibition of mTOR in the signal transduction pathway. 
 
Figure 6.3: Showing binding of Curcin with mTOR in cartoon view 
Discussion: The above observation indicates that Curcin does not have a direct role in signaling 
pathway via mTOR. As mTOR – Rapamycin complex formation is necessary for inhibition of cell 
proliferation by arresting the cell in G1 phase; the role of Curcin is not significant in this respect. 
However the limitations of in-silico study apply here very well as the above interaction may not be 
practically feasible in-vivo. 
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Interaction of Curcin with EGFR 
The docking operation of „Curcin‟ ligand was performed with „EGFR complex intracellular 
domain‟ as receptor. The results were compared with docking operation using „Potato 
Carboxypeptidase Inhibitor‟ ligand as positive control. 
 
Fig 6.4 (a): Cartoon image showing binding of Curcin[RED] with EGFR (left) and Potato 
Carboxypeptidase Inhibitor[GOLD] with EGFR (right) 
 
Potato Carboxypeptidase Inhibitor (PCI) being a protease inhibitor is observed to bind with the 
tyrosine kinase domain of EGFR. This site specific binding of ligand with EGFR inhibits 
formation of receptor dimer and also prevents receptor trans-autophosphorylation, thus inhibiting 
cell proliferation. Curcin is also observed to show a similarity in binding properties with EGFR 
targeting the same domain of EGFR as done by PCI. Further images below show the localization 
of both proteins in the same EGFR domain as seen by the merged image of individual binding 
results. 
~ 34 ~ 
 
 
Fig 6.4 (b): Cartoon image showing co-localization of Curcin [RED] and PCI [PINK] in the 
same domain of EGFR (left). The image is created by merging images of individual docking 
data. To aid visually the Curcin [RED] is shifted a bit so that PCI [GOLD] is visible clearly 
(right). 
  
The E-total value obtained from the above two docking procedures were observed as show below: 
Table  6.3: Results obtained after performing docking using HEX 6.3 
Orientations Curcin PCI 
 
1 
 
-266.80 
 
-253.50 
 
2 
 
-262.80 
 
-246.60 
 
3 
 
-225.30 
 
-216.90 
  
Discussion: The comparable E-total values suggest that successful docking of Curcin with EGFR 
tyrosine kinase domain is energetically possible as in the case of natural inhibitor protein PCI. 
Therefore it can be predicted that Curcin can also inhibit cell proliferation by preventing the EGFR 
signal transduction pathway, thus acting as an anti tumor agent. 
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Conclusions                    
By modeling Curcin, we identify useful templates that are showing good similarity with Curcin 
and show an antitumor activity. Interestingly, one of the models derived from comparative or 
homology modeling in SWISS-MODEL (best QMEAN4 value) was validated and displayed 
several meaningful features: secondary structure, charge distribution, conserved residues engaged 
in non-bonded interaction. Since the above work is an in-vitro study, the predicted protein model 
of Curcin (which proves its efficacy after docking studies) has to go for clinical trials to establish 
its effectiveness to develop new inhibitor against tumor. The laticifer proteins of Jatropha curcas 
can be further tested on mammalian cell lines both normal and cancerous in future for analyzing 
the growth potential for use of laticiferous extract as a natural medication. The above work aims to 
serve all those researchers for further studies to help the patients who are currently experiencing 
this disease. As of till now only little information is available about the biochemical and 
pharmaceutical properties of Jatropha curcas latex. Hopefully this study will help in aiding further 
developments in field of natural therapeutic approaches.       
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CLUSTAL 2.0.12 MULTIPLE SEQUENCE ALIGNMENT
File: /home/sandeep/Desktop/sequences/Curcin/curcin 293.ps Date: Wed May  4 16:18:03 2011

Page 1 of 2
                                                          :                                 :   :*            * :                               .      :: :                       
1ONK_A|PDBID|CHAIN|SEQUENCE ---------------------------YERLRLRVTH------------------QTTGEEYFRFITLLRDYVSSGSFS-NEIPLLRQSTIPVSDAQRFVLVELTNQGQDSVTAAIDVTN-AYVVAYQAGDQSYFLR----DAPRGAETH    99
2RG9_A|PDBID|CHAIN|SEQUENCE ---------------------------YERLSLRTVQ------------------QTTGEEYFSFITLLRDFVSSGSFS-NNIPLLRQSTIPVSEASRFVLVELTNEGGDSITAAIDVTN-LYVVAYQAGQQSYFLK----DAPRGAETQ    99
2VC3_A|PDBID|CHAIN|SEQUENCE ----------------------IFPKQYPIINFTTAG-------------------ATVQSYTNFIRAVRGRLTTGADVRHEIPVLPNRVGLPINQR-FILVELSNHAELSVTLALDVTN-AYVVGYRAGNSAYFFHPDNQEDAEAITHL   107
3BJG_A|PDBID|CHAIN|SEQUENCE ---------------------AIFPKQYPIINFTTAG-------------------ATVQSYTNFIRAVRGRLTTGADVRHEIPVLPNRVGLPINQR-FILVELSNHAELSVTLALDMTN-AAVVGYRAGNSAYFFHPDNQEDAEAITHL   108
gi|42542983|pdb|1J1M|A ---------------------MIFPKQYPIINFTTAG-------------------ATVQSYTNFIRAVRGRLTTGADVRHEIPVLPNRVGLPINQR-FILVELSNHAELSVTLALDVTN-AYVVGYRAGNSAYFFHPDNQEDAEAITHL   108
3EJ5_X|PDBID|CHAIN|SEQUENCE --------------------------QYPIINFTTAG-------------------ATVQSYTNFIRAVRGRLTTGADVRHEIPVLPNRVGLPINQR-FILVELSNHAELSVTLALDVTN-AYVVGYRAGNSAYFFHPDNQEDAEAITHL   103
gi|40889788|pdb|1UQ4|A --------------------------QYPIINFTTAG-------------------ATVQSYTNFIRAVRGRLTTGADVRHEIPVLPNRVGLPINQR-FILVELSNHAELSVTLALDVTN-AYVVGYRAGNSAYFFHPDNQEDAEAITHL   103
1BRY_Y|PDBID|CHAIN|SEQUENCE ----------------------------MDVSFRLSG-------------------ATTTSYGVFIKNLREALPYERKV-YNIPLLRSSISGSGR---YTLLHLTNYADETISVAVDVTN-VYIMGYLAGDVSYFFN--EASATEAAKFV    96
1BRY_Z|PDBID|CHAIN|SEQUENCE ----------------------------MDVSFRLSG-------------------ATTTSYGVFIKNLREALPYERKV-YNIPLLRSSISGSGR---YTLLHLTNYADETISVAVDVTN-VYIMGYLAGDVSYFFN--EASATEAAKFV    96
2VS6_A|PDBID|CHAIN|SEQUENCE ----------------------------MDVSFRLSG-------------------ATSSSYGVFISNLRKALPNERKL-YDIPLLRSSLPGSQR---YALIHLTNYADETISVAIDVTN-VYIMGYRAGDTSYFFN--EASATEAAKYV    96
2VS6_B|PDBID|CHAIN|SEQUENCE ----------------------------MDVSFRLSG-------------------ATSSSYGVFISNLRKALPNERKL-YDIPLLRSSLPGSQR---YALIHLTNYADETISVAIDVTN-VYIMGYRAGDTSYFFN--EASATEAAKYV    96
2JJR_A|PDBID|CHAIN|SEQUENCE -----------------------------DVSFRLSG-------------------ATSSSYGVFISNLRKALPNERKL-YDIPLLRSSLPGSQR---YALIHLTNYADETISVAIDVTN-VYIMGYRAGDTSYFFN--EASATEAAKYV    95
3MRW_A|PDBID|CHAIN|SEQUENCE -----------------------------DVSFRLSG-------------------ADPSSYGMFIKDLRNALPHTEKV-YNIPLLLPSVSGAGR---YLLMHLFNYDGNTITVAVDVTN-VYIMGYLALTTSYFFN--EPAADLASQYV    95
3MRY_A|PDBID|CHAIN|SEQUENCE -----------------------------DVSFRLSG-------------------ADPSSYGMFIKDLRNALPHTEKV-YNIPLLLPSVSGAGR---YLLMHLFNYDGNTITVAVDVTN-VYIMGYLALTTSYFHN--EPAADLASQYV    95
3N1D_A|PDBID|CHAIN|SEQUENCE -----------------------------DVSFRLSG-------------------ADPSSYGMFIKDLRNALPHTEKV-YNIPLLLPSVSGAGR---YLLMHLFNYDGNTITVAVDVTN-VYIMGYLALTTSYFFN--EPAADLASQYV    95
1MOM_A|PDBID|CHAIN|SEQUENCE -----------------------------DVSFRLSG-------------------ADPRSYGMFIKDLRNALPFREKV-YNIPLLLPSVSGAGR---YLLMHLFNYDGKTITVALDVTN-VYIMGYLADTTSYFFN--EPAAELASQYV    95
2OQA_A|PDBID|CHAIN|SEQUENCE -----------------------------DVSFSLSG-------------------SSSTSYSKFIGALRKALPSNGTV-YNITLLLSSASGASR---YTLMKLSNYDGKAITVAIDVTN-VYIMGYLVNSTSYFFN--ESDAKLASQYV    95
2OQA_B|PDBID|CHAIN|SEQUENCE -----------------------------DVSFSLSG-------------------SSSTSYSKFIGALRKALPSNGTV-YNITLLLSSASGASR---YTLMKLSNYDGKAITVAIDVTN-VYIMGYLVNSTSYFFN--ESDAKLASQYV    95
gi|209156420|pdb|3BWH|A -----------------------------NVRFDLSS-------------------ATSSSYKTFIKNLREALPKDGKV-YDIPVLLSTVMDSRR---FILIDLVNYDGQSITAAIDVLN-VYIVAYSTGTVSYFFQ--QVPA-QAPKLL    94
tr|Q8VYU0|Q8VYU0_9ROSI MKGGKMNLSIMVAAWFCWSCIIFGWASAREIVCPFSSNQNYKAGSTPTLTITYDAAADKKNYAQFIKDLREAFGFSYSS-HEIPVLRATVAPNQK---FIVAKVINVANLEVSLGLNVVN-AYLVGYKVGGTSYFFN--DPESLADAKTY   143
3KTZ_A|PDBID|CHAIN|SEQUENCE --------------------------GLDTVSFSTKG-------------------ATYITYVNFLNELRVKLKPEGNS-HGIPLLRKKCDDPGKC--FVLVALSNDNGQLAEIAIDVTS-VYVVGYQVRNRSYFFK--DAPDAAYEG--    97
3KTZ_B|PDBID|CHAIN|SEQUENCE --------------------------GLDTVSFSTKG-------------------ATYITYVNFLNELRVKLKPEGNS-HGIPLLRKKCDDPGKC--FVLVALSNDNGQLAEIAIDVTS-VYVVGYQVRNRSYFFK--DAPDAAYEG--    97
1ONK_B|PDBID|CHAIN|SEQUENCE ----------------------------DDVTCSASEP-----------------TVRIVGRNGMRVDVRDDDFHDGNQ---IQLWPSKSNNDPNQLWTIKRDGTIRSNGSCLTTYGYTAGVYVMIFDCNTAVREATIWQIWDNGTIINP   102
2RG9_B|PDBID|CHAIN|SEQUENCE ----------------------------DDVTCSASEP-----------------IVRIVGRNGMTVDVRDDDFQDGNQ---IQLWPSKSNNDPNQLWTIKKDGTIRSNGSCLTTYGYTAGVYVMIFDCNTAVREATIWQIWGNGTIINP   102
                    1.......10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150
                                         *.   .        :    *       :                . ..        :  :   :                      :..  .  *                  :         :           : 
1ONK_A|PDBID|CHAIN|SEQUENCE LFTGTTRSSLPFNGSYPDLERYA-GHRDQIPLGIDQLIQSVTALRFPGGS---TRTQARSILILIQMISEAARFNPILWRYRQYINSGASFLPDVYMLELETSWGQQSTQVQ--HSTDGVFNNPIRLAIPPGNFVTLTNVRDVIASLAIM   243
2RG9_A|PDBID|CHAIN|SEQUENCE DFTGTTRSSLPFNGSYPDLERYA-GHRDQIPLGIDQLIQSVTALRFPGGS---TRTQARSILILIQMISEAARFNPILWRARQYINSGASFLPDVYMLELETSWGQQSTQVQ--HSTDGVFNNPIRLALPPGNVVTLTNIRDVIASLAIM   243
2VC3_A|PDBID|CHAIN|SEQUENCE FTDVQNRYTFAFGGNYDRLEQLAGNLRENIELGNGPLEEAISALYYYSTGGTQLPTLARSFIICIQMISDAARFQYIEGEMRTRIRYNRRSAPDPSVITLENSWGRLSTAIQ--ESNQGAFASPIQLQRRNGSKFSVYDVSILIPIIALM   255
3BJG_A|PDBID|CHAIN|SEQUENCE FTDVQNRYTFAFGGNYDRLEQLAGNLRENIELGNGPLEEAISALYYYSTGGTQLPTLARSFIICIQMISEAARFQYIEGEMRTRIRYNRRSAPDPSVITLENSWGRLSTAIQ--ESNQGAFASPIQLQRRNGSKFSVYDVSILIPIIALM   256
gi|42542983|pdb|1J1M|A FTDVQNRYTFAFGGNYDRLEQLAGNLREDIELGNGPLEEAISALYYYSTGGTQLPTLARSFIICIQMISEAARFQYIEGEMRTRIRYNRRSAPDPSVITLENSWGRLSTAIQ--ESNQGAFASPIQLQRRNGSKFSVYDVSILIPIIALM   256
3EJ5_X|PDBID|CHAIN|SEQUENCE FTDVQNRYTFAFGGNYDRLEQLAGNLRENIELGNGPLEEAISALYYYSTGGTQLPTLAISFIICIQMISEAARFQYIEGEMRTRIRYNRRSAPDPSVITLENSWGRLSTAIQ--ESNQGAFASPIQLQRRNGSKFSVYDVSILIPIIALM   251
gi|40889788|pdb|1UQ4|A FTDVQNRYTFAFGGNYDRLEQLAGNLRENIELGNGPLEEAISALYYYSTGGTQLPTLARSFIICIQMISEAARFQYIEGEMRTRIRYNRRSAPDPSVITLENSWGDLSTAIQ--ESNQGAFASPIQLQRRNGSKFSVYDVSILIPIIALM   251
1BRY_Y|PDBID|CHAIN|SEQUENCE FKDAKKKVTLPYSGNYERLQTAAGKIRENIPLGLPALDSAITTLYYYT-----ASSAASALLVLIQSTAESARYKFIEQQIGKRVDKTFL--PSLATISLENNWSALSKQIQIASTNNGQFESPVVLIDGNNQRVSITNASARVVTSNIA   239
1BRY_Z|PDBID|CHAIN|SEQUENCE FKDAKKKVTLPYSGNYERLQTAAGKIRENIPLGLPALDSAITTLYYYT-----ASSAASALLVLIQSTAESARYKFIEQQIGKRVDKTFL--PSLATISLENNWSALSKQIQIASTNNGQFESPVVLIDGNNQRVSITNASARVVTSNIA   239
2VS6_A|PDBID|CHAIN|SEQUENCE FKDAMRKVTLPYSGNYERLQTAAGKIRENIPLGLPALDSAITTLFYYN-----ANSAASALMVLIQSTSEAARYKFIEQQIGAAVDATFL--PSLAIISLENSWSALSKQIQIASTNNGQFESPVVLINAQNQRVTITNVDAGVVTSNIA   239
2VS6_B|PDBID|CHAIN|SEQUENCE FKDAMRKVTLPYSGNYERLQTAAGKIRENIPLGLPALDSAITTLFYYN-----ANSAASALMVLIQSTSEAARYKFIEQQIGAAVDATFL--PSLAIISLENSWSALSKQIQIASTNNGQFESPVVLINAQNQRVTITNVDAGVVTSNIA   239
2JJR_A|PDBID|CHAIN|SEQUENCE FKDAMRKVTLPYSGNYERLQTAAGKIRENIPLGLPALDSAITTLFYYN-----ANSAASALMVLIQSTSEAARYKFIEQQIGKRVDKTFL--PSLAIISLENSWSALSKQIQIASTNNGQFESPVVLINAQNQRVTITNVDAGKVTSDIA   238
3MRW_A|PDBID|CHAIN|SEQUENCE FRSARRKITLPYSGNYERLQIAAGKPREKIPIGLPALDTAISTLLHYD-----STAAAGALLVLIQTTAEAARFKYIEQQIQERAYRDEV--PSSATISLENSWSGLSKQIQLAQGNNGVFRTPTVLVDSKGNRVQITNVTSNVVTSNIQ   238
3MRY_A|PDBID|CHAIN|SEQUENCE FRSARRKITLPYSGNYDRLQIAAGKPREKIPIGLPALDTAISTLLHYD-----STAAAGALLVLIQTTAEAARFKYIEQQIQERAYRDEV--PSSATISLENSWSGLSKQIQLAQGNNGVFRTPTVLVDSKGNRVQITNVTSNVVTSNIQ   238
3N1D_A|PDBID|CHAIN|SEQUENCE FRSARRKITLPYSGNYERLQIAAGKPREKIPIGLPALDTAISTLLHYD-----STAAAGALLVLIQTTAEAARFKYIEQQIQERAYRDEV--PSSATISLENSWSGLSKQIQLAQGNNGVFRTPTVLVDSGGNRVQITNVTSNVVTSNIQ   238
1MOM_A|PDBID|CHAIN|SEQUENCE FRDARRKITLPYSGNYERLQIAAGKPREKIPIGLPALDSAISTLLHYD-----STAAAGALLVLIQTTAEAARFKYIEQQIQERAYRDEV--PSLATISLENSWSGLSKQIQLAQGNNGIFRTPIVLVDNKGNRVQITNVTSKVVTSNIQ   238
2OQA_A|PDBID|CHAIN|SEQUENCE FAGS-TIVTLPYSGNYEKLQTAAGKIREKIPLGFPALDSAITTLFHYD-----STAAAAAFLVIIQTTAESSRFKYIEGQIIMRISKNGV--PSLATISLENEWSALSKQIQLAQTNNGTFKTPVVIMDAGGQRVEIGNVGSKVVTKNIQ   237
2OQA_B|PDBID|CHAIN|SEQUENCE FAGS-TIVTLPYSGNYEKLQTAAGKIREKIPLGFPALDSAITTLFHYD-----STAAAAAFLVIIQTTAESSRFKYIEGQIIMRISKNGV--PSLATISLENEWSALSKQIQLAQTNNGTFKTPVVIMDAGGQRVEIGNVGSKVVTKNIQ   237
gi|209156420|pdb|3BWH|A FKGT-QQRTLPYTGNYENLQTAAKKLRENIELGLPALDSAITTLFHYN-----AEAAASALLVLIQTTSEAARFRYIELQIANNVGTKFK--PSQTIISLENNWSALSKQIQIAKNKNGQFETPVILIDPQGNRVQITNVTSNVVTQNIQ   236
tr|Q8VYU0|Q8VYU0_9ROSI LFTDTKQQTLSFTGSYADFLSRANVHREDVDLGVQALDNYIYTLEKSSK----PADIAKPLVGFIEMVPEAARFKYIEKKVLSQISKTLR--PGGDIISLENNWGDLSYQIQKCVN--GVFLKPVQLQRENYTNILVNNVTQVAGVMGVL   285
3KTZ_A|PDBID|CHAIN|SEQUENCE LFKNTIKTRLHFGGSYPSLEGEK-AYRETTDLGIEPLRIGIKKLDENAIDNYKPTEIASSLLVVIQMVSEAARFTFIENQIRNNFQQRIR--PANNTISLENKWGKLSFQIRTSGAN-GMFSEAVELERANGKKYYVTAVDQVKPKIALL   243
3KTZ_B|PDBID|CHAIN|SEQUENCE LFKNTIKTRLHFGGSYPSLEGEK-AYRETTDLGIEPLRIGIKKLDENAIDNYKPTEIASSLLVVIQMVSEAARFTFIENQIRNNFQQRIR--PANNTISLENKWGKLSFQIRTSGAN-GMFSEAVELERANGKKYYVTAVDQVKPKIALL   243
1ONK_B|PDBID|CHAIN|SEQUENCE RSNLVLAASSGIKGTTLTVQTLDYTLGQGWLAGNDTAPREVTIYGFRDLC---MESNGGSVWVETCDSSQKNQKWALYGDGSIRPKQNQDQCLTSGRDSVSTVINIVSCSGASGSQRWVFTNEGAILNLKNGLAMDVAQANPKLRRIIIY   249
2RG9_B|PDBID|CHAIN|SEQUENCE RSNLVLAASSGIKGTTLTVQTLDYTLGQGWLAGNDTAPREVTIYGFRDLC---MESNGGSVWVETCTIGQENQRWALYGDGSIRPKQNQSQCLTNGRDSVSTVINIVSCSAGSSGQRWVFTNEGAILNLKNGLAMDVAQANPKLRRIIIY   249
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1ONK_A|PDBID|CHAIN|SEQUENCE LFVCGERPSSS---   254
2RG9_A|PDBID|CHAIN|SEQUENCE LFVCGE--------   249
2VC3_A|PDBID|CHAIN|SEQUENCE VYRCAPPPSSQF--   267
3BJG_A|PDBID|CHAIN|SEQUENCE VYRCAPPPSSQF--   268
gi|42542983|pdb|1J1M|A VYRCAPPPSSQF--   268
3EJ5_X|PDBID|CHAIN|SEQUENCE VYRCAP--------   257
gi|40889788|pdb|1UQ4|A VYRCAPPPSSQF--   263
1BRY_Y|PDBID|CHAIN|SEQUENCE LLLNRNNIA-----   248
1BRY_Z|PDBID|CHAIN|SEQUENCE LLLNRNNIA-----   248
2VS6_A|PDBID|CHAIN|SEQUENCE LLLNRNNMA-----   248
2VS6_B|PDBID|CHAIN|SEQUENCE LLLNRNNMA-----   248
2JJR_A|PDBID|CHAIN|SEQUENCE LLLNRNNMA-----   247
3MRW_A|PDBID|CHAIN|SEQUENCE LLLNTKNI------   246
3MRY_A|PDBID|CHAIN|SEQUENCE LLLNTKNI------   246
3N1D_A|PDBID|CHAIN|SEQUENCE LLLNTKNI------   246
1MOM_A|PDBID|CHAIN|SEQUENCE LLLNTRNI------   246
2OQA_A|PDBID|CHAIN|SEQUENCE LLLN----------   241
2OQA_B|PDBID|CHAIN|SEQUENCE LLLN----------   241
gi|209156420|pdb|3BWH|A LLLNIGATA-----   245
tr|Q8VYU0|Q8VYU0_9ROSI LNAVNYKV------   293
3KTZ_A|PDBID|CHAIN|SEQUENCE KFVDKDPK------   251
3KTZ_B|PDBID|CHAIN|SEQUENCE KFVDKDPK------   251
1ONK_B|PDBID|CHAIN|SEQUENCE PATGKPNQMWLPVF   263
2RG9_B|PDBID|CHAIN|SEQUENCE PATGNPNQMWLPVP   263
                    .......310....
